That's great you're following autism research! Here's some of the latest:

For Dravet syndrome (which sometimes has autism traits), the gene-regulation therapy zorevunersen shows seizure reductions up to 91% in kids, plus improvements in cognition, behavior, and more. Phase 3 trials are enrolling! See emperorstudy.com.

In Rett syndrome, gene therapies are entering Phase 3 trials. Check out the IRSF's 2026 webinar for details: https://www.youtube.com/watch?v=HRqav2LwkxI. The ASCEND 2026 Summit (June 15-2 will also cover new treatments: https://www.rettsyndrome.org/event/ascend2026/.

UCLA is hosting "Advances in Autism 2026" on May 8, covering diagnosis and interventions. There's also a webinar on Dec 2, 2026 about gut issues and behavior in autism.